Cathepsin S inhibitor compounds
    1.
    发明授权
    Cathepsin S inhibitor compounds 失效
    组织蛋白酶S抑制剂化合物

    公开(公告)号:US08227468B2

    公开(公告)日:2012-07-24

    申请号:US13273302

    申请日:2011-10-14

    CPC分类号: C07D407/14 C07D407/04

    摘要: The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof. Also, the present invention provides a pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof with a pharmaceutically acceptable diluent or carrier. The present invention further provides methods for treating abdominal aortic aneurysm, plaque instability, atherosclerosis, or autoimmune disorders such as rheumatoid arthritis, psoriasis, and lupus comprising administering a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof and a pharmaceutically acceptable diluent or carrier.

    摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐。 此外,本发明提供了包含式(I)化合物或其药学上可接受的盐与药学上可接受的稀释剂或载体的药物组合物。 本发明还提供了治疗腹主动脉瘤,斑块不稳定性,动脉粥样硬化或自身免疫疾病如类风湿性关节炎,牛皮癣和狼疮的方法,其包括施用治疗有效量的式(I)化合物或其药学上可接受的盐或 包含式(I)化合物或其药学上可接受的盐和药学上可接受的稀释剂或载体的药物组合物。